Alcon (CH:ALC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Alcon, a global leader in eye care, has reported a strong start to 2024 with first-quarter sales rising to $2.4 billion, marking a 5% increase from the previous year, and a substantial 43% growth in diluted earnings per share at $0.50. Their performance was particularly bolstered by robust sales in the contact lens segment and significant operational cash flow improvements. The company’s shareholders also approved a dividend of CHF 0.24 per share during the Annual General Meeting.
For further insights into CH:ALC stock, check out TipRanks’ Stock Analysis page.
